Case Study

Patient & Provider Drivers of Cancer Genetic Testing (BRCA & HRD)

Quick Facts

250 Conditions supported across 40 therapeutic areas

270 Engagements in the last 5 years

100+ Pre-commercial assets supported in the last 5 years

Objective

Identify the drivers and barriers for patients to undergo genetic testing in breast, prostate, and ovarian cancer and test receptivity to educational materials focused on the importance of genetic testing (particularly BRCA and HRD).

Approach

  • Conduct interviews with patients across tumor types to understand their awareness of genetic testing, perceived barriers associated with genetic testing, and their receptivity to educational materials on testing
  • Conduct interviews with oncologists across tumor types to pressure-test patient findings and further understand the dynamics between provider and patient as it relates to genetic testing; providers were also shown the educational materials to gauge receptivity
  • Understand the key leverage points in the patient journey related to decision-making for genetic testing and highlight differences between tumor types
  • Synthesize key findings on receptivity to education materials for both providers and patient stakeholders and determine how information was best disseminated

Results

Project findings informed refinement to awareness campaigns and informed a better understanding of inflection points in the patient journey for each tumor type.

Patient journey across prescriber ecosystem in breast, ovarian, and prostate cancer
Archetypes of undertested patients and strategies to increase activation
Skip to toolbar